Does angioedema in patients with chronic spontaneous urticaria impact response to omalizumab?
-
Published:2024-08
Issue:8
Volume:17
Page:100943
-
ISSN:1939-4551
-
Container-title:World Allergy Organization Journal
-
language:en
-
Short-container-title:World Allergy Organization Journal
Author:
Casale Thomas B.ORCID,
Trzaskoma Benjamin,
Holden Michael,
Bernstein Jonathan A.,
Maurer Marcus
Reference10 articles.
1. Angioedema in chronic spontaneous urticaria is underdiagnosed and has a substantial impact: analyses from ASSURE-CSU;Sussman;Allergy,2018
2. Angioedema in the omalizumab chronic idiopathic/spontaneous urticaria pivotal studies;Zazzali;Ann Allergy Asthma Immunol,2016
3. Patients with chronic spontaneous urticaria who have wheals, angioedema, or both, differ demographically, clinically, and in response to treatment - results from CURE;Buttgereit;J Allergy Clin Immunol Pract,2023
4. Effect of omalizumab on angioedema in H1-antihistamine-resistant chronic spontaneous urticaria patients: results from X-ACT, a randomized controlled trial;Staubach;Allergy,2016
5. Omalizumab for chronic urticaria;Maurer;N Engl J Med,2013